UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Teva Pharmaceuticals
TEVA
$41.2B
| $16.7M | 0.01% |
1,830,406
+153,181
| +9% | +$1.34M |
|
752
Weatherford International
WFRD
$6.22B
| $16.6M | 0.01% |
326,617
+252,945
| +343% | +$10.4M |
|
753
Forward Air
FWRD
$654M
| $16.4M | 0.01% |
156,120
+8,812
| +6% | +$925K |
|
754
WillScot Mobile Mini Holdings
WSC
$4.41B
| $16.3M | 0.01% |
361,124
-3,203
| -0.9% | -$144K |
|
755
Builders FirstSource
BLDR
$8.04B
| $16.3M | 0.01% |
251,145
-12,032
| -5% | -$751K |
|
756
Casey's General Stores
CASY
$30.9B
| $16.3M | 0.01% |
72,464
+12,133
| +20% | +$2.76M |
|
757
ManpowerGroup
MAN
$2.63B
| $16M | 0.01% |
192,698
+70,432
| +58% | +$5.65M |
|
758
COPT Defense Properties
CDP
$4.21B
| $16M | 0.01% |
616,539
+50,847
| +9% | +$1.31M |
|
|
AYX
759
DELISTED
Alteryx Inc
AYX
| $16M | 0.01% |
315,338
+17,434
| +6% | +$832K |
|
760
Cirrus Logic
CRUS
$6.26B
| $15.8M | 0.01% |
212,722
-682
| -0.3% | -$49.1K |
|
|
AXON
761
Axon Enterprise
AXON
$46.4B
| $15.8M | 0.01% |
95,016
+6,222
| +7% | +$984K |
|
762
Tenable Holdings
TENB
$4.01B
| $15.7M | 0.01% |
412,214
+17,931
| +5% | +$658K |
|
763
Sarepta Therapeutics
SRPT
$1.77B
| $15.7M | 0.01% |
121,321
+1,254
| +1% | +$145K |
|
|
SILK
764
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $15.6M | 0.01% |
295,249
+21,577
| +8% | +$1.05M |
|
765
Lincoln Electric
LECO
$15.4B
| $15.5M | 0.01% |
106,996
+4,246
| +4% | +$596K |
|
766
Five Below
FIVE
$13.5B
| $15.4M | 0.01% |
87,031
+3,269
| +4% | +$514K |
|
767
Watsco Inc
WSO
$13.6B
| $15.3M | 0.01% |
61,383
+6,176
| +11% | +$1.62M |
|
768
Douglas Emmett
DEI
$1.96B
| $15.3M | 0.01% |
975,434
+116,185
| +14% | +$1.93M |
|
769
argenx
ARGX
$54.1B
| $15.2M | 0.01% |
40,143
+87
| +0.2% | +$32.5K |
|
770
Sensata Technologies
ST
$6.79B
| $15.2M | 0.01% |
376,462
-36
| -0% | -$1.5K |
|
771
Matador Resources
MTDR
$6.09B
| $15.2M | 0.01% |
264,971
+15,438
| +6% | +$974K |
|
|
AGR
772
DELISTED
Avangrid, Inc.
AGR
| $15.1M | 0.01% |
352,178
-105,974
| -23% | -$4.39M |
|
773
Denali Therapeutics
DNLI
$3.97B
| $15.1M | 0.01% |
543,923
+13,719
| +3% | +$408K |
|
774
Roku
ROKU
$22.7B
| $15M | 0.01% |
368,480
-5,960
| -2% | -$311K |
|
|
BERY
775
DELISTED
Berry Global Group, Inc.
BERY
| $14.9M | 0.01% |
268,223
+4,855
| +2% | +$238K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.